News & Updates

The incidence of death is comparable between patients with acute myocardial infarction (MI) without heart failure (HF) receiving angiotensin II receptor blockers (ARBs) and those taking angiotensin-converting enzyme inhibitors (ACEIs), a study has shown.

Use of SGLT-2 inhibitors may reduce the risk of all-cause and cardiovascular (CV) mortality in patients with heart failure (HF) with reduced ejection fraction (HFrEF), reports a study.

A diet that is rich in fruits and vegetables can help treat individuals with primary hypertension by preventing chronic kidney disease (CKD) progression and reducing the risk of cardiovascular disease (CVD), suggest the results of a recent study.